Neuroinflammation, Gut-Brain Axis and Depression

키워드

참고문헌 (82)

1. Gerhard DM, "Emerging treatment mechanisms for depression : focus on glutamate and synaptic plasticity", Drug Discov Today, 21, pp.454~464 (2016)
2. Ledford H, "Medical research : if depression were cancer", Nature, 515, pp.182~184 (2014)
3. Smith K, "Mental health : a world of depression", Nature, 515, pp.181~ (2014)
4. Belmaker RH, "Major depression disorder", N Engl J Med, 358, pp.55~68 (2008)
5. Corfield EC, "A continuum of genetic liability for minor and major depression", Transl Psychiatry, 7, pp.e1131~ (2017)
6. Bukh JD, "Interaction between genetic polymorphisms and stressful life events in first episode depression", J Affect Disord, 119, pp.107~115 (2009)
7. Alper Evrensel, "The Gut-Brain Axis: The Missing Link in Depression", Clinical Psychopharmacology and Neuroscience, 13(3), pp.239~244 (2015), 대한정신약물학회
8. Evrensel A, "Frontiers in Psychiatry. Advances in Experimental Medicine and Biology, vol 1192", pp.565~581 (2019), Springer
9. Stahl SM, "Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications" (2013), Cambridge University Press
10. Pytka K, "The role of glutamatergic, gaba-ergic, and cholinergic receptors in depression and antidepressant-like effect", Pharmacol Rep, 68, pp.443~450 (2016)
11. Liu B, "From serotonin to neuroplasticity : evolvement of theories for major depressive disorder", Front Cell Neurosci, 11, pp.305~ (2017)
12. Barden N, "Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression", J Psychiatry Neurosci, 29, pp.185~193 (2004)
13. Juruena MF, "The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression", Braz J Psychiatry, 26, pp.189~201 (2004)
14. Evrensel A, "Therapeutic potential of the microbiome in the treatment of neuropsychiatric disorders", Med Sci(Basel), 7, pp.21~ (2019)
15. Seferovic MD, "Visualization of microbes by 16s in situ hybridization in term and preterm placentae without ıntraamniotic ınfection", Am J Obstet Gynecol, 221, pp.146.e1~146.e23 (2019)
16. Honda K, "The microbiota in adaptive immune homeostasis and disease", Nature, 535, pp.75~84 (2016)
17. Sudo N, "Microbiome, HPA axis and production of endocrine hormones in the gut", Adv Exp Med Biol, 817, pp.177~194 (2014)
18. Bien-Ly N, "The blood-brain barrier’s gut check", Sci Transl Med, 6, pp.263fs46~ (2014)
19. Ogbonnaya ES, "Adult hippocampal neurogenesis ıs regulated by the microbiome", Biol Psychiatry, 78, pp.e7~e9 (2015)
20. Hoban AE, "Regulation of prefrontal cortex myelination by the microbiota", Transl Psychiatry, 6, pp.e774~ (2016)
21. Jiang H, "Altered fecal microbiota composition in patients with major depressive disorder", Brain Behav Immun, 48, pp.186~194 (2015)
22. Liu Y, "Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression", Clin Gastroenterol Hepatol, 14, pp.1602~1611 (2016)
23. Aizawa E, "Possible association of bifidobacterium and lactobacillus in the gut microbiota of patients with major depressive disorder", J Affect Disord, 202, pp.254~257 (2016)
24. Park AJ, "Altered colonic function and microbiota profile in a mouse model of chronic depression", Neurogastroenterol Motil, 25, pp.733~e575 (2013)
25. Yu M, "Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC", MS-based metabolomics, 2017, pp.138, 231~239
26. Lin P, "Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder", J Affect Disord, 207, pp.300~304 (2017)
27. Zheng P, "Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism", Mol Psychiatry, 21, pp.786~796 (2016)
28. Kelly JR, "Transferring the blues : Depression-associated gut microbiota ınduces neurobehavioural changes in the rat", J Psychiatr Res, 82, pp.109~118 (2016)
29. GBD 2016 DALYs and HALE Collaborators, "Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016", Lancet, 390, pp.1260~1344 (2017)
30. Lurie I, "Antibiotic exposure and the risk for depression, anxiety, or psychosis : a nested case-control study", J Clin Psychiatry, 76, pp.1522~1528 (2015)
31. Frohlich EE; Farzi A, "Cognitive impairment by antibiotic-ınduced gut dysbiosis : analysis of gut microbiota-brain communication", Brain Behav Immun, 56, pp.140~155 (2016)
32. Bercik P, "The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis", Adv Exp Med Biol, 817, pp.279~289 (2014)
33. Kohler O, "Infections and exposure to anti-ınfective agents and the risk of severe mental disorders : A nationwide study", Acta Psychiatr Scand, 135, pp.97~105 (2017)
34. Slykerman RF, "Antibiotics in the first year of life and subsequent neurocognitive outcomes", Acta Paediatr, 106, pp.87~94 (2017)
35. Slykerman RF, "Exposure to antibiotics in the first 24 months of life and neurocognitive outcomes at 11 years of age", Psychopharmacology(Berl), 236, pp.1573~1582 (2019)
36. Bereswill S, "A possible link between food and mood : dietary ımpact on gut microbiota and behavior in BALB", c mice, 2014, pp.9, e103398~
37. Oriach CS, "Food for thought : the role of nutrition in the microbiota-gut–brain axis", Clin Nutr Exp, 6, pp.25~38 (2016)
38. Owen L, "The role of diet and nutrition on mental health and wellbeing", Proc Nutr Soc, 76, pp.425~426 (2017)
39. Slyepchenko A, "Gut microbiota, bacterial translocation, and ınteractions with diet : pathophysiological links between major depressive disorder and non-communicable medical comorbidities", Psychother Psychosom, 86, pp.31~46 (2017)
40. Noble EE, "Gut to brain dysbiosis : mechanisms linking western diet consumption, the microbiome, and cognitive ımpairment", Front Behav Neurosci, 1, pp.9~ (2017)
41. Jeon SW, "The role of neuroinflammation and neurovascular dysfunction in major depressive disorder", J Inflamm Res, 11, pp.179~192 (2018)
42. Carvalho LA, "Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system", J Affect Disord, 148, pp.136~140 (2013)
43. Kiecolt-Glaser JK, "Inflammation : depression fans the flames and feasts on the heat", Am J Psychiatry, 172, pp.1075~1091 (2015)
44. Miller AH, "The role of inflammation in depression : from evolutionary imperative to modern treatment target", Nat Rev Immunol, 16, pp.22~34 (2016)
45. Woelfer M, "The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder", Neuroscience, 403, pp.93~110 (2019)
46. Song C, "Cytokines mediated inflammation and decreased neurogenesis in animal models of depression", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.760~768 (2011)
47. Dantzer R, "From inflammation to sickness and depression : when the immune system subjugates the brain", Nat Rev Neurosci, 9, pp.46~56 (2008)
48. Berk M, "So depression is an inflammatory disease, but where does the inflammation come from?", BMC Med, 11, pp.200~ (2013)
49. Moylan S, "Oxidative and nitrosative stress in depression: why so much stress?", Neurosci Biobehav Rev, 45, pp.46~62 (2014)
50. Shelton RC, "Eating ourselves to death(and despair) : the contribution of adiposity and in ammation to depression", Prog Neurobiol, 91, pp.275~299 (2010)
51. Raison CL, "Inflammatory depression : a trifecta of trouble", J Clin Psychiatry, 75, pp.663~664 (2014)
52. Kopschina Feltes P, "Anti-inflammatory treatment for major depressive disorder : implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy", J Psychopharmacol, 31, pp.1149~1165 (2017)
53. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67, pp.446~457 (2010)
54. Smith RS, "The macrophage theory of depression", Med Hypotheses, 35, pp.298~306 (1991)
55. Liu Y, "Interleukin(IL)-6, tumour necrosis factor alpha(TNF-α)and soluble interleukin-2 receptors(sIL-2R)are elevated in patients with major depressive dis-order : a meta-analysis and meta-regression", J Affect Disord, 139, pp.230~239 (2012)
56. Sukoff Rizzo SJ, "Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes", Transl Psychiatry, 2, pp.e199~ (2012)
57. Rawdin B, "Dysregulated relationship of inflammation and oxidative stress in major depression", Brain Behav Immun, 31, pp.143~152 (2013)
58. Krogh J, "The association between depressive symptoms, cognitive function, and inflammation in major depression", Brain Behav Immun, 35, pp.70~76 (2014)
59. Lanquillon S, "Cytokine production and treatment response in major depressive disorder", Neuropsychopharmacol, 22, pp.370~379 (2000)
60. O’Brien SM, "Cytokines : abnormalities in major depression and implications for pharmacological treatment", Hum Psychopharmacol, 19, pp.397~403 (2004)
61. Agus A, "Gut microbiota regulation of tryptophan metabolism in health and disease", Cell Host Microbe, 23, pp.716~724 (2018)
62. Maes M, "The gut-brain barrier in major depression : intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria(leaky gut)plays a role in the inflammatory pathophysiology of depression", Neuro Endocrinol Lett, 29, pp.117~124 (2008)
63. Zhang JC, "Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis", Transl Psychiatry, 7, pp.e1138~ (2017)
64. Rieder R, "Microbes and mental health : a review", Brain Behav Immun, 66, pp.9~17 (2017)
65. Grenham S, "Brain-gut-microbe communication in health and disease", Front Physiol, 2, pp.94~ (2011)
66. Alper Evrensel, "Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders", Clinical Psychopharmacology and Neuroscience, 14(3), pp.231~237 (2016), 대한정신약물학회
67. Sandhu KV, "Feeding the microbiota-gut-brain axis : Diet, microbiome, and neuropsychiatry", Transl Res, 179, pp.223~244 (2017)
68. Gibson GR, "Expert consensus document : The International Scientific Association For Probiotics And Prebiotics(ISAPP)consensus statement on the definition and scope of prebiotics", Nat Rev Gastroenterol Hepatol, 14, pp.491~502 (2017)
69. Bollrath J, "Immunology. Feed your Tregs more fiber", Science, 341, pp.463~464 (2013)
70. Dinan TG, "Psychobiotics : A novel class of psychotropic", Biol Psychiatry, 74, pp.720~726 (2013)
71. Phillips JGP, "The treatment of melancholia by the lactic acid bacillus", Br J Psychiatry, 56, pp.422~431 (1910)
72. Pirbaglou M, "Probiotic supplementation can positively affect anxiety and depressive symptoms : a systematic review of randomized controlled trials", Nutr Res, 36, pp.889~898 (2016)
73. Wallace CJK, "The effects of probiotics on depressive symptoms in humans : A systematic review", Ann Gen Psychiatry, 16, pp.14~ (2017)
74. Liang S, "Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress", Neuroscience, 310, pp.561~577 (2015)
75. Akkasheh G, "Clinical and metabolic response to probiotic administration in patients with major depressive disorder : A randomized, double-blind, placebo-controlled trial", Nutrition, 32, pp.315~320 (2016)
76. Abildgaard A, "Probiotic treatment reduces depressive-like behaviour in rats independently of diet", Psychoneuroendocrinology, 79, pp.40~48 (2017)
77. Evrensel A, "Treatment Resistance in Psychiatry", pp.369~376 (2019), Springer
78. Evrensel A, "The effect of fecal microbiota transplantation on psychiatric symptoms among patients with inflammatory bowel disease: an experimental study", Actas Esp Psiquiatr (2019)
79. Stahl SM, "Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis : dopamine, serotonin, and glutamate", CNS Spectrums, 23, pp.187~191 (2018)
80. Macedo D, "Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible ımplications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness", J Affect Disord, 208, pp.22~32 (2017)
81. Bambling M, "Combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort : an intestinal anti-inflammatory response is suggested", Inflammopharmacology, 25, pp.271~274 (2017)
82. Ng QX, "A meta-analysis of the use of probiotics to alleviate depressive symptoms", J Affect Disord, 228, pp.13~19 (2018)

관련 논문AI추천